Brought to you by 
Public offering nets $109.3mm for Tandem Diabetes
Aug 2018
Executive Summary
Tandem Diabetes Care Inc. (manufactures and sells insulin pumps and glucose monitoring devices) netted $109.3mm through the public sale of 4mm common shares (including the overallotment) at $28.50. The company will use some or all of the proceeds to repay debt under an existing term loan agreement with Capital Royalty.
Deal Industry
-
In Vitro Diagnostics
- Glucose Testing
-
Medical Devices
- Monitoring Equipment & Devices
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com